Global Life Science Analytics Market, By Type (Predictive, Descriptive, Prescriptive), Component (Software, Service), Delivery Model (On Premise, On-Demand Model), Application (Research and Development, Sales and Marketing, Pharmacovigilance, Regulatory Compliance, Supply Chain Optimization), End Use (Pharmaceutical and Biotechnology Companies, Medical Device Companies, Research Centers, Third-Party Administrators) – Industry Trends and Forecast to 2031.
Life Science Analytics Market Analysis and Size
Pharmacovigilance, within the realm of life science analytics market, encompasses the systematic monitoring, assessment, and prevention of adverse effects or any other drug-related problems. It employs sophisticated analytics tools and methodologies to gather, analyze, and interpret data from various sources such as clinical trials, post-marketing surveillance, and spontaneous reporting systems. These analytics help in identifying patterns, trends, and potential risks associated with pharmaceutical products, thereby ensuring the safety and efficacy of medications. Through advanced analytics, pharmacovigilance enables timely intervention, regulatory compliance, and informed decision-making by pharmaceutical companies, regulatory agencies, and healthcare providers, ultimately safeguarding public health.
Global life science analytics market size was valued at USD 5.80 billion in 2023 and is projected to reach USD 10.82 billion by 2031, with a CAGR of 8.1% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024-2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Predictive, Descriptive, Prescriptive), Component (Software, Service), Delivery Model (On Premise, On-Demand Model), Application (Research and Development, Sales and Marketing, Pharmacovigilance, Regulatory Compliance, Supply Chain Optimization), End Use (Pharmaceutical and Biotechnology Companies, Medical Device Companies, Research Centers, Third-Party Administrators)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Sweden, Poland, Denmark, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa , Brazil, Argentina, Rest of South America
|
|
Market Players Covered
|
SAS Institute Inc. (U.S.), IBM Corporation (U.S.), Oracle (U.S.), IQVIA Inc (U.S.)., Accenture (Ireland), Cognizant (U.S.), Wipro (India), Applexus Technologies (India), Saama Technologies, LLC (U.S.)., Incedo Inc. (U.S.), CitiusTech Inc (U.S.)., Siemens (Germany), Rockwell Automation (U.S.), Infosys Limited (India), Navitas Life Sciences (India)
|
|
Market Opportunities
|
|
Market Definition
Life sciences analytics encompasses analytical tools utilized across pharmaceutical, medical device firms, and clinical research organizations, spanning various sectors such as research, marketing, pharmacovigilance, and supply chain management. It involves the analysis of clinical data to provide predictive insights, enhancing patient care and facilitating informed decision-making across the life sciences industry.
Life Science Analytics Market Dynamics
Drivers
- Increasing Demand for Data-Driven Insights for Enhanced Decision-Making
As the life sciences industry continues to generate vast amounts of data from research, clinical trials, and patient records, there is a growing recognition of the value that analytics can bring in extracting actionable insights. Life science companies are leveraging advanced analytics tools to analyze this data comprehensively, leading to enhanced decision-making in areas such as drug discovery, personalized medicine, and clinical trial optimization. Harnessing the power of data analytics, these companies can uncover patterns, trends, and correlations that were previously hidden, ultimately improving efficiency, and driving innovation in the life sciences sector.
- Increasing Advancements in Technology Promotes Better Patient Care
Advancements in artificial intelligence, machine learning, and big data analytics empower researchers and healthcare professionals to extract actionable insights from vast and complex datasets, driving the growth of life science intelligence. These technologies enable more accurate prediction of drug responses, identification of potential risks, and discovery of new therapeutic targets, thereby accelerating the drug development process. Moreover, advancements in data visualization and cloud computing facilitate real-time monitoring of clinical trials and pharmacovigilance activities, enhancing efficiency and safety in healthcare delivery. Overall, the continuous evolution of technology serves as a catalyst for innovation and growth within the life science analytics sector, driving improvements in patient care and outcomes.
For instance, the partnership between Accenture and Trifacta exemplifies how advancements in technology drive the life science analytics market. Accenture's expertise in analytics, combined with Trifacta's data mining capabilities, aims to enhance drug discovery procedures through the design of efficient and advanced data mining techniques. This collaboration harnesses cutting-edge technology to enable pharmaceutical companies to extract valuable insights from large datasets, accelerating the drug development process and ultimately improving patient outcomes.
Opportunities
- Growing Regulatory Pressures Reduces the Risk of Non-Compliance Penalties
Regulatory agencies worldwide impose stringent requirements regarding drug safety, efficacy, and reporting standards, compelling life science companies to invest in advanced analytics solutions to meet these standards efficiently. Analytics platforms enable companies to monitor adverse events, assess safety signals, and ensure compliance with evolving regulatory frameworks. Additionally, analytics-driven insights help streamline regulatory reporting processes, reducing the risk of non-compliance penalties and facilitating faster market approvals for new drugs. In essence, the demand for comprehensive analytics solutions arises from the imperative to navigate complex regulatory landscapes effectively while maintaining high standards of safety and compliance in the life sciences industry.
- Increasing Collaborations Among the Consumers Increases the Adoption of Analytics in Life Sciences
Life science companies, academic institutions, and technology providers pool their expertise and resources to develop more sophisticated analytics solutions by joining forces. These collaborations foster innovation by combining domain knowledge with advanced analytics capabilities, leading to the creation of more comprehensive and specialized tools tailored to the specific needs of the life sciences market. Partnerships facilitate access to diverse datasets, enabling more robust analysis and insights. Ultimately, these collaborative efforts accelerate the adoption of analytics in life sciences marketing, driving growth and advancements in the market.
For instance, In January 2021, Oracle and Cognizant united their technological capabilities to advance the life science analytics market. Their collaboration, utilizing Oracle's Health Science solutions and Cognizant's Shared Investigator Platform, aims to expedite clinical trial studies through innovative analytics solutions. This partnership underscores the industry's trend towards collaborative efforts, driving innovation and addressing specific challenges within the life sciences sector.
Restraints/Challenges
- Increased Data Security Concerns Limits the Seamless Flow of Information for Analysis
With the abundance of sensitive patient data involved in analytics processes, including medical records and genomic information, ensuring compliance with stringent privacy regulations such as GDPR and HIPAA becomes paramount. The need to protect this data from unauthorized access, breaches, and misuse adds complexity and cost to implementing analytics solutions. Striking a balance between leveraging data for insights and safeguarding individual privacy rights poses ongoing challenges for companies operating in this space.
- Shortage of Skilled People Limits Optimizing Analytics Solutions
Rapid advancements in analytics technologies demand a skilled workforce proficient in data science, biostatistics, and life sciences domain knowledge. However, there is a scarcity of professionals possessing these specialized skills. This shortage poses challenges in implementing and optimizing analytics solutions within pharmaceutical, biotech, and healthcare organizations.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In February 2022, Databricks launched the Databricks Lakehouse for Healthcare and Life Sciences, a comprehensive platform integrating analytics, data management, and advanced AI capabilities. This solution streamlines processes in healthcare and life sciences, enabling tasks ranging from medical image classification to disease prediction and biomarker discovery to be performed efficiently on a single platform
- In July 2022, Charles River Associates launched the Healthcare Claims Analytics Platform (HCAP) at the World Orphan Drug Congress U.S. 2022 in Boston. HCAP leverages the potency of machine learning and patient analytics to enhance market understanding and facilitate informed decision-making in the healthcare sector. This suite empowers stakeholders with actionable insights derived from data analysis and predictive modeling, contributing to improved healthcare outcomes
Life Science Analytics Market Scope
The market is segmented on the basis of type, component, delivery model, application and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Predictive
- Descriptive
- Prescriptive
Component
- Software
- Service
Delivery Model
- On Premise
- On-Demand Model
Application
- Research and Development
- Sales and Marketing
- Pharmacovigilance
- Regulatory Compliance
- Supply Chain Optimization
End Use
- Pharmaceutical and Biotechnology Companies
- Medical Device Companies
- Research Centers
- Third-Party Administrators
Life Science Analytics Market Regional Analysis/Insights
The market is analyzed and market size insights and trends are provided by country, type, component, delivery model, application and end use as referenced above.
The countries covered in the market report are U.S., Canada, Mexico, Germany, Sweden, Poland, Denmark, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa , Brazil, Argentina and rest of South America.
North America is expected to dominate the market primarily due to its well-established and continuously evolving healthcare infrastructure. The region's dominance is further fueled by factors such as a rising elderly population and the escalating prevalence of non-communicable diseases. These demographic and epidemiological trends contribute to a favorable environment for market expansion, fostering increased demand for healthcare services, technologies, and solutions in North America during the forecast period.
Asia-Pacific is expected for substantial growth in the life science analytics market, driven by significant technological advancements and the presence of major industry players. This growth is fueled by the development of innovative care models, which are anticipated to further propel market expansion in the years ahead. With a focus on leveraging data analytics to optimize healthcare delivery and outcomes, the region is becoming increasingly pivotal in shaping the future of life sciences and healthcare analytics on a global scale.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.
Competitive Landscape and Life Science Analytics Market Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and Development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the market are:
- SAS Institute Inc. (U.S.)
- IBM Corporation (U.S.)
- Oracle (U.S.)
- IQVIA Inc (U.S.).
- Accenture (Ireland)
- Cognizant (U.S.)
- Wipro (India)
- Applexus Technologies (India)
- Saama Technologies, LLC (U.S.).
- Incedo Inc. (U.S.)
- CitiusTech Inc (U.S.)
- Siemens (Germany)
- Rockwell Automation (U.S.)
- Infosys Limited (India)
- Navitas Life Sciences (India)
SKU-